ZABBIO - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87628754
Word Mark
ZABBIO
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-06-29
Filing Date
2017-09-29
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-04-02
Attorney Name
Law Office Assigned Location Code
N50
Employee Name
LAMONT, JOHN CHRISTOPH
Statements
Goods and Services
Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagents for chemical analysis, other than for medical or veterinary purposes; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in infectious disease research
Goods and Services
Antibody-based pharmaceutical products for use in the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, urological diseases and disorders, viral and infectious diseases, cancer, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes, contraceptives and hemolytic diseases and disorders; Antibody-based pharmaceutical preparations, namely, cholesterol reducing preparations, osteoporosis prevention preparations, oncological preparations for the prevention and treatment of cancer, dermatological preparations, urological preparations, ophthalmologic preparations, preparations for the treatment of damaged tissue and skin, contraceptives and gynecological estrogen preparations; Antibody-based pharmaceuticals, namely, anti-infectives; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids, including for microorganisms; Drug delivery agents consisting of compounds that facilitate delivery of antibody-based pharmaceuticals; Antibody-based antibacterial pharmaceuticals; Antibody-based cardiovascular pharmaceuticals; Antibody-based contraceptive films; Oral, systemic and topical contraceptives; Antibody-based pharmaceutical products for use in preventing and treating infectious diseases
Goods and Services
Contraceptive apparatus; Intra uterine contraceptive devices; Contraceptive vaginal rings; Medical apparatus for introducing pharmaceutical preparations into the human body
Goods and Services
Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, viral and infectious diseases, cancer, urological diseases and disorders, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, migraines and headaches, pain, hypertension, inflammation and inflammatory diseases and disorders, metabolic diseases and disorders, respiratory and infectious diseases and disorders, immunological, bacterial, viral and fungal diseases and disorders, psychiatric diseases and disorders, asthma, allergies, diabetes, obesity, stroke, erectile and sexual dysfunction, sexually transmitted infections including, but not limited to, HIV, HPV, and herpes and hemolytic diseases and disorders; research and development of pharmaceutical preparations, namely, cholesterol preparations, osteoporosis preparations, oncological preparations, dermatological preparations, urological preparations, contraceptives, ophthalmologic preparations, tissue and skin repair preparations and gynecological preparations; research and development of drug delivery devices; medical and scientific research, namely, conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to infectious disease prevention and therapy
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2017-10-05
Primary Code
001
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2017-10-05
Primary Code
010
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2017-10-05
Primary Code
042
Correspondences
Name
PAUL NARDULLI
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2017-10-03 | NEW APPLICATION ENTERED IN TRAM |
2017-10-05 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-01-08 | ASSIGNED TO EXAMINER |
2018-01-08 | NON-FINAL ACTION WRITTEN |
2018-01-08 | NON-FINAL ACTION MAILED |
2018-05-14 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-05-14 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-05-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-05-17 | SUSPENSION LETTER WRITTEN |
2018-05-17 | LETTER OF SUSPENSION MAILED |
2019-01-10 | ASSIGNED TO LIE |
2019-01-11 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
2019-01-31 | NON-FINAL ACTION WRITTEN |
2019-01-31 | NON-FINAL ACTION MAILED |
2019-02-26 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-02-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-02-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-02-27 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-03-13 | NOTICE OF PUBLICATION |
2019-04-02 | PUBLISHED FOR OPPOSITION |
2019-05-28 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2019-11-12 | TEAS EXTENSION RECEIVED |
2019-11-12 | EXTENSION 1 FILED |
2019-11-12 | EXTENSION 1 GRANTED |
2019-11-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED |
2020-06-29 | ABANDONMENT - NO USE STATEMENT FILED |
2020-06-29 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |